acquired
Stage
About
Audentes Therapeutics was a biotechnology company focused on developing AAV-based gene therapies for rare neuromuscular diseases and inherited disorders before being acquired by Astellas Pharma in 2019.
Explore Audentes Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.